{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:41:53Z","timestamp":1793396513416,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11606-019-04850-w","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T13:45:44Z","timestamp":1549287944000},"page":"535-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults\u2019 Perspectives"],"prefix":"10.1007","volume":"34","author":[{"given":"Christina J.","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bangsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Toevs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Nicolaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"4850_CR1","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010\u20132015. HIV Surveill Suppl Rep. 2018;23(1)."},{"key":"4850_CR2","unstructured":"Gilead. U.S. Food and Drug Administration approves Gilead\u2019s Truvada\u00ae for reducing the risk of acquiring HIV. Available at: https:\/\/www.gilead.com\/news\/press-releases\/2012\/7\/us-food-and-drug-administration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv. Accessed November 13, 2018."},{"issue":"12","key":"4850_CR3","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973\u20131983.","journal-title":"AIDS."},{"issue":"27","key":"4850_CR4","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"R Grant","year":"2010","unstructured":"Grant R, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u20132599.","journal-title":"N Engl J Med."},{"issue":"1","key":"4850_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","volume":"64","author":"LA Grohskopf","year":"2013","unstructured":"Grohskopf LA, Chillag KL, Gvetadze R, et al. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013;64(1):79\u201386.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"10013","key":"4850_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet."},{"issue":"2","key":"4850_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s15010-015-0850-2","volume":"44","author":"CD Spinner","year":"2016","unstructured":"Spinner CD, Boesecke C, Zink A, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151\u2013158.","journal-title":"Infection."},{"key":"4850_CR8","unstructured":"Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2017 update: a clinical practice guideline. Available at: \n                    https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf\n                    \n                  . Accessed November 13, 2018."},{"issue":"10","key":"4850_CR9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","volume":"61","author":"JE Volk","year":"2015","unstructured":"Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61(10):1601\u20131603.","journal-title":"Clin Infect Dis."},{"key":"4850_CR10","doi-asserted-by":"crossref","unstructured":"Okwundu CI, Uthman OA, Okoromah CAN. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;(7):CD007189.","DOI":"10.1002\/14651858.CD007189.pub3"},{"key":"4850_CR11","unstructured":"National Center for HIV\/AIDS Viral Hepatitis STD and TB Prevention. HIV prevention pill not reaching most Americans who could benefit - especially people of color. Available at: \n                    https:\/\/www.cdc.gov\/nchhstp\/newsroom\/2018\/croi-2018-PrEP-press-release.html\n                    \n                  . Accessed November 13, 2018."},{"issue":"10","key":"4850_CR12","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/cid\/civ664","volume":"61","author":"CF Kelley","year":"2015","unstructured":"Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590\u20131597.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"4850_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/QAI.0000000000001251","volume":"74","author":"JT Parsons","year":"2017","unstructured":"Parsons JT, Rendina HJ, Lassiter JM, Whit THF, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. J Acquir Immune Defic Syndr. 2017;74(3):285\u2013292.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"9","key":"4850_CR14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1080\/09540121.2011.554528","volume":"23","author":"RA Brooks","year":"2011","unstructured":"Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee S-J, Leibowitz AA. Motivators, concerns, and barriers to adoption of pre-exposure prophylaxis for HIV prevention among gay and bisexual men in HIV serodiscordant male relationships. AIDS Care. 2011;23(9):1136\u20131145.","journal-title":"AIDS Care."},{"issue":"1","key":"4850_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1748-5908-7-116","volume":"7","author":"GR Galindo","year":"2012","unstructured":"Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7(1):116.","journal-title":"Implement Sci."},{"issue":"11","key":"4850_CR16","doi-asserted-by":"publisher","first-page":"e50061","DOI":"10.1371\/journal.pone.0050061","volume":"7","author":"P Saberi","year":"2012","unstructured":"Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7(11):e50061.","journal-title":"PLoS One."},{"issue":"7","key":"4850_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/13691058.2017.1380230","volume":"20","author":"M Thomann","year":"2018","unstructured":"Thomann M, Grosso A, Zapata R, Chiasson MA. \u201cWTF is PrEP?\u201d: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Cult Health Sex. 2018;20(7):772\u2013786.","journal-title":"Cult Health Sex."},{"issue":"2","key":"4850_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10461-013-0560-7","volume":"18","author":"I Young","year":"2014","unstructured":"Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195\u2013216.","journal-title":"AIDS Behav."},{"issue":"7","key":"4850_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/1570162X12666140129100411","volume":"11","author":"JA Bauermeister","year":"2013","unstructured":"Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res. 2013;11(7):520\u2013527.","journal-title":"Curr HIV Res."},{"issue":"4","key":"4850_CR20","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s10461-017-2011-3","volume":"22","author":"A Hannaford","year":"2018","unstructured":"Hannaford A, Lipshie-Williams M, Starrels JL, et al. The use of online posts to identify barriers to and facilitators of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men: a comparison to a systematic review of the peer-reviewed literature. AIDS Behav. 2018;22(4):1080\u20131095.","journal-title":"AIDS Behav."},{"issue":"4","key":"4850_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/apc.2012.0419","volume":"27","author":"SA Golub","year":"2013","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248\u2013254.","journal-title":"AIDS Patient Care STDS."},{"issue":"3","key":"4850_CR22","doi-asserted-by":"publisher","first-page":"e1001613","DOI":"10.1371\/journal.pmed.1001613","volume":"11","author":"A Liu","year":"2014","unstructured":"Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.","journal-title":"PLoS Med."},{"issue":"1","key":"4850_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/apc.2017.0153","volume":"32","author":"D Grace","year":"2018","unstructured":"Grace D, Jollimore J, MacPherson P, Strang MJP, Tan DHS. The pre-exposure prophylaxis-stigma paradox: learning from Canada\u2019s first wave of PrEP users. AIDS Patient Care STDS. 2018;32(1):24\u201330.","journal-title":"AIDS Patient Care STDS."},{"issue":"10","key":"4850_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/apc.2013.0116","volume":"27","author":"HJ Gilmore","year":"2013","unstructured":"Gilmore HJ, Liu A, Koester KA, et al. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDS. 2013;27(10):560\u2013566.","journal-title":"AIDS Patient Care STDS."},{"issue":"1","key":"4850_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","volume":"74","author":"SG Hosek","year":"2017","unstructured":"Hosek SG, Rudy B, Landovitz R, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21\u201329.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"7","key":"4850_CR26","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10461-015-1055-5","volume":"20","author":"J Carlo Hojilla","year":"2016","unstructured":"Carlo Hojilla J, Koester KA, Cohen SE, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461\u20131469.","journal-title":"AIDS Behav."},{"issue":"1","key":"4850_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","volume":"176","author":"AY Liu","year":"2016","unstructured":"Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Intern Med. 2016;176(1):75\u201384.","journal-title":"JAMA Intern Med."},{"issue":"12","key":"4850_CR28","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/13691058.2017.1310927","volume":"19","author":"K Koester","year":"2017","unstructured":"Koester K, Amico RK, Gilmore H, et al. Risk, safety and sex among male PrEP users: time for a new understanding. Cult Health Sex. 2017;19(12):1301\u20131313.","journal-title":"Cult Health Sex."},{"issue":"Suppl 1","key":"4850_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/09540121.2016.1146653","volume":"28","author":"L Sagaon-Teyssier","year":"2016","unstructured":"Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, et al. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care. 2016;28(Suppl 1):48\u201355.","journal-title":"AIDS Care."},{"issue":"7","key":"4850_CR30","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s10461-016-1360-7","volume":"20","author":"KR Amico","year":"2016","unstructured":"Amico KR, Mehrotra M, Avelino-Silva VI, et al. Self-reported recent PrEP dosing and drug detection in an open label PrEP study. AIDS Behav. 2016;20(7):1535\u20131540.","journal-title":"AIDS Behav."},{"issue":"11","key":"4850_CR31","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s10461-018-2184-4","volume":"22","author":"RM Pinto","year":"2018","unstructured":"Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681\u20133691.","journal-title":"AIDS Behav."},{"issue":"4","key":"4850_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1089\/apc.2017.0002","volume":"31","author":"SK Calabrese","year":"2017","unstructured":"Calabrese SK, Magnus M, Mayer KH, et al. \u201cSupport your client at the space that they\u2019re in\u201d: HIV pre-exposure prophylaxis (PrEP) prescriber\u2019s perspectives on PrEP-related risk compensation. AIDS Patient Care STDS. 2017;31(4):196\u2013204.","journal-title":"AIDS Patient Care STDS."},{"issue":"4","key":"4850_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/lgbt.2017.0101","volume":"5","author":"RR Patel","year":"2018","unstructured":"Patel RR, Chan PA, Harrison LC, et al. Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis, Missouri. LGBT Heal. 2018;5(4):250\u2013256.","journal-title":"LGBT Heal."},{"issue":"4","key":"4850_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/apc.2014.0273","volume":"29","author":"TLK Mullins","year":"2015","unstructured":"Mullins TLK, Lally M, Zimet G, Kahn JA. Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents. AIDS Patient Care STDS. 2015;29(4):193\u2013203.","journal-title":"AIDS Patient Care STDS."},{"issue":"7","key":"4850_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/apc.2012.0030","volume":"26","author":"JM White","year":"2012","unstructured":"White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395\u2013405.","journal-title":"AIDS Patient Care STDS."},{"issue":"2","key":"4850_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11904-016-0308-x","volume":"13","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, Volk JE, Pinder J, et al. Successful implementation of HIV pre-exposure prophylaxis: lessons learned from three clinical settings. Curr HIV\/AIDS Rep. 2016;13(2):116\u2013124.","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"12","key":"4850_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1089\/apc.2015.0186","volume":"29","author":"S Parker","year":"2015","unstructured":"Parker S, Chan PA, Oldenburg CE, et al. Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care STDS. 2015;29(12):639\u2013642.","journal-title":"AIDS Patient Care STDS."},{"issue":"2","key":"4850_CR38","doi-asserted-by":"publisher","first-page":"e0172354","DOI":"10.1371\/journal.pone.0172354","volume":"12","author":"T Arnold","year":"2017","unstructured":"Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS One. 2017;12(2):e0172354.","journal-title":"PLoS One."},{"issue":"11","key":"4850_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/OLQ.0000000000000514","volume":"43","author":"PA Chan","year":"2016","unstructured":"Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of pre-exposure prophylaxis for HIV prevention among men who have sex with men at a New England sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717\u2013723.","journal-title":"Sex Transm Dis."},{"key":"4850_CR40","unstructured":"U.S. Preventive Services Task Force. Draft recommendation statement: Prevention of human immunodeficiency virus (HIV) infection: pre-exposure prophylaxis. Available from: \n                    https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-recommendation-statement\/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis\n                    \n                  . Accessed January 30, 2019."},{"issue":"2","key":"4850_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol."},{"issue":"1","key":"4850_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1\u201313.","journal-title":"Int J Qual Methods."},{"issue":"1","key":"4850_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2325957415600798","volume":"15","author":"S Hoffman","year":"2016","unstructured":"Hoffman S, Guidry JA, Collier KL, et al. A clinical home for preexposure prophylaxis: diverse health care providers\u2019 perspectives on the \u201cpurview paradox.\u201d. J Int Assoc Provid AIDS Care. 2016;15(1):59\u201365.","journal-title":"J Int Assoc Provid AIDS Care."},{"issue":"9","key":"4850_CR44","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s10461-014-0839-3","volume":"18","author":"D Krakower","year":"2014","unstructured":"Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers\u2019 perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712\u20131721.","journal-title":"AIDS Behav."},{"issue":"7","key":"4850_CR45","doi-asserted-by":"publisher","first-page":"e40603","DOI":"10.1371\/journal.pone.0040603","volume":"7","author":"EA Arnold","year":"2012","unstructured":"Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7(7):e40603.","journal-title":"PLoS One."},{"issue":"1","key":"4850_CR46","doi-asserted-by":"publisher","first-page":"21165","DOI":"10.7448\/IAS.19.1.21165","volume":"19","author":"DS Krakower","year":"2016","unstructured":"Krakower DS, Maloney KM, Grasso C, Melbourne K, Mayer KH. Primary care clinicians\u2019 experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016;19(1):21165.","journal-title":"J Int AIDS Soc."},{"issue":"7","key":"4850_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/apc.2017.0031","volume":"31","author":"DS Krakower","year":"2017","unstructured":"Krakower DS, Ware NC, Maloney KM, Wilson IB, Wong JB, Mayer KH. Differing experiences with pre-exposure prophylaxis in Boston among lesbian, gay, bisexual, and transgender specialists and generalists in primary care: implications for scale-up. AIDS Patient Care STDS. 2017;31(7):297\u2013304.","journal-title":"AIDS Patient Care STDS."},{"issue":"11","key":"4850_CR48","doi-asserted-by":"publisher","first-page":"e112425","DOI":"10.1371\/journal.pone.0112425","volume":"9","author":"K Underhill","year":"2014","unstructured":"Underhill K, Morrow KM, Colleran CM, et al. Access to healthcare, HIV\/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the U.S. PLoS One. 2014;9(11):e112425.","journal-title":"PLoS One."},{"issue":"5","key":"4850_CR49","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10461-016-1663-8","volume":"21","author":"CH Bien","year":"2017","unstructured":"Bien CH, Patel VV., Blackstock OJ, Felsen UR. Reaching key populations: PrEP uptake in an urban health care system in the Bronx, New York. AIDS Behav. 2017;21(5):1309\u20131314.","journal-title":"AIDS Behav."},{"issue":"1","key":"4850_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1521\/aeap.2018.30.1.1","volume":"30","author":"A Braksmajer","year":"2018","unstructured":"Braksmajer A, Fedor TM, Chen SR, et al. Willingness to take prep for HIV prevention: the combined effects of race\/ethnicity and provider trust. AIDS Educ Prev. 2018;30(1):1\u201312.","journal-title":"AIDS Educ Prev."},{"issue":"1","key":"4850_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11606-016-3903-z","volume":"32","author":"OJ Blackstock","year":"2017","unstructured":"Blackstock OJ, Moore BA, Berkenblit G V., et al. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2017;32(1):62\u201370.","journal-title":"J Gen Intern Med."},{"issue":"5","key":"4850_CR52","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","volume":"21","author":"AE Petroll","year":"2017","unstructured":"Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among U.S. primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256\u20131267.","journal-title":"AIDS Behav."},{"issue":"5","key":"4850_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s10461-015-0996-z","volume":"19","author":"J Blumenthal","year":"2015","unstructured":"Blumenthal J, Jain S, Krakower D, et al. Knowledge is power!: increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescript PrEP. AIDS Behav. 2015;19(5):802\u2013810.","journal-title":"AIDS Behav."},{"issue":"1","key":"4850_CR54","doi-asserted-by":"publisher","first-page":"e0146139","DOI":"10.1371\/journal.pone.0146139","volume":"11","author":"J Whitehead","year":"2016","unstructured":"Whitehead J, Shaver J, Stephenson R. Outness, stigma, and primary health care utilization among rural LGBT populations. PLoS One. 2016;11(1):e0146139.","journal-title":"PLoS One."},{"key":"4850_CR55","unstructured":"Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, D.C.: The National Academies Press; 2011."},{"issue":"1","key":"4850_CR56","doi-asserted-by":"publisher","first-page":"20903","DOI":"10.7448\/IAS.19.1.20903","volume":"19","author":"PA Chan","year":"2016","unstructured":"Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three U.S. cities. J Int AIDS Soc. 2016;19(1):20903.","journal-title":"J Int AIDS Soc."},{"issue":"5","key":"4850_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/1090198117752789","volume":"45","author":"LM Adams","year":"2018","unstructured":"Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives preexposure prophylaxis (PrEP)?: a brief online survey of medical providers\u2019 PrEP practices. Heal Educ Behav. 2018;45(5):723\u2013729.","journal-title":"Heal Educ Behav."},{"key":"4850_CR58","unstructured":"National Minority AIDS Council. National HIV and PrEP Navigation Landscape Assessment. Available from: \n                    http:\/\/www.nmac.org\/wp-content\/uploads\/2017\/11\/National-HIV-and-PrEP-Navigation-Landscape-Assessment-Report.pdf\n                    \n                  . Accessed November 13, 2018."},{"issue":"6","key":"4850_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11096-012-9709-0","volume":"34","author":"C Bruno","year":"2012","unstructured":"Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012;34(6):803\u2013806.","journal-title":"Int J Clin Pharm."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-019-04850-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-04850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-04850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T20:14:55Z","timestamp":1580760895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-019-04850-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4850"],"URL":"https:\/\/doi.org\/10.1007\/s11606-019-04850-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Portland State University Institutional Review Board approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the Oregon AIDS Education and Training Center at Portland Veterans Affairs Research Foundation and Agency for Healthcare Research and Quality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}